SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cary Frank T – ‘4’ for 9/10/02 re: Vion Pharmaceuticals Inc.

On:  Thursday, 9/12/02, at 11:42am ET   ·   For:  9/10/02   ·   Accession #:  950117-2-2143   ·   File #:  0-26534

Previous ‘4’:  ‘4’ on 10/14/99 for 10/4/99   ·   Next:  ‘4’ on 12/11/02 for 12/9/02   ·   Latest:  ‘4’ on / for 12/29/05

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/12/02  Cary Frank T                      4          Director    1:11K  Vion Pharmaceuticals Inc.         Command F… Self-Filer/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Vion Pharmaceuticals Inc                               5±    22K 

41st “Page” of 2TOCTopPreviousNextBottomJust 1st
 

Form 4 Page 1 of 2 [Download Table] ---------------------------- --------------- OMB APPROVAL FORM 4 ---------------------------- --------------- OMB Number: 3235-0287 ---------------------------- Expires: January 31, 2005 ---------------------------- Estimated average burden hours per response... 0.5 ---------------------------- [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). (Print or Type Responses) [Enlarge/Download Table] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 [Enlarge/Download Table] ------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol Cary Frank T. Vion Pharmaceuticals, Inc. (Vion) ------------------------------------------------------------------------------------------------------------------------ (Last) (First) (Middle) 3. I.R.S. Identification 4. Statement for Number of Reporting Month/Day/Year Person, if an entity September 10, 2002 (voluntary) c/o Vion Pharmaceuticals, Inc. 4 Science Park ------------------------------------------------------------------------------------------------------------------------ (Street) 5. If Amendment, Date of Original (Month/Day/Year) New Haven, CT 06511 ------------------------------------------------------------------------------------------------------------------------ (City) (State) (Zip) --------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner -------- ------- Officer (give Other (specify -------- title below) ------- below) --------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person ------ Form filed by More than One Reporting Person ------ --------------------------------------------------------------- [Enlarge/Download Table] -------------------------------------------------------------------------------------------------------------------------- Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned -------------------------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Transaction Date 2A. Deemed 3. Transaction 4. Securities Acquired (A) (Instr. 3) (Month/Day/Year) Execution Code or Disposed of (D) Date, (Instr.8) (Instr. 3, 4 and 5) if any --------------------------------------------------------- (Month/ Code V Amount (A) or Price Day/ (D) Year) -------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ 5. Amount of 6. Ownership 7. Nature of Securities Form: Direct Indirect Beneficially (D) or Indirect (I) Beneficial Owned Following (Instr. 4) Ownership Reported Transaction(s) (Instr. 4) (Instr. 3 and 4) ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------
4Last “Page” of 2TOC1stPreviousNextBottomJust 2nd
Form 4 Page 2 of 2 Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) [Enlarge/Download Table] -------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative 2. Conver- 3. Trans- 3A. Deemed Execution 4. Transac- 5. Number of Security (Instr. 3) sion or action Date, if any tion Code Derivative Exercise Date (Month/Day/Year) (Instr. 8) Securities Price of (Month/ Acquired (A) Derivative Day/ or Disposed of Security Year) (D) (Instr. 3, 4, and 5) ----------------------------------- Code V (A) (D) Option to Purchase $0.43 9/10/2002 A 5,882 -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- 6. Date Exercisable 7. Title and Amount of 8. Price of 9. Number of and Expiration Date Underlying Securities Derivative Derivative (Month/Day/Year) (Instr. 3 and 4) Security Securities (Instr. 5) Beneficially Owned Following Reported Transaction(s) (Instr. 4) ------------------------ ----------------------------------------------------------------- Date Expi- Title Amount or Exercis- ration Number of able Date Shares (1) 9/10/2012 Common Stock 5,882 66,425 ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------ 10. Ownership 11. Nature Form of of Indirect Derivative Beneficial Securities Ownership Beneficially (Instr. 4) Owned at End of Month (Instr. 4) Direct ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- Explanation of Responses: (1) Option is exercisable 100% on the first anniversary of the date of grant. /s/ Frank T. Cary 9/12/02 -------------------------------- ----------------- **Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. *If the form is filed by more than one reporting person, see Instruction 4(b)(v). **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘4’ Filing    Date First  Last      Other Filings
1/31/051
Filed on:9/12/024
For Period end:9/10/0214
 List all Filings 
Top
Filing Submission 0000950117-02-002143   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 1:26:13.1pm ET